1. Argenti D, D’Mello P (1994). The pharmacodynamics of desipramine and desmethyldesipramine in rats. J Pharmacol Exp Ther 270: 512–519.
2. Amano T, Aoki S, Setsuie R, Sakurai M, Wada K, Noda M (2006). Identification of a novel regulatory mechanism for norepinephrine transporter activity by the IP3 receptor. Eur J Pharmacol 536: 62–68.
3. Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD (1998a). Acute regulation of norepinephrine transporter: I. Protein kinase C-linked muscarinic receptors influence transporter capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Ther 287: 733–743.
4. Apparsundaram S, Schroeter S, Giovanetti E, Blakely RD (1998b). Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. J Pharmacol Exp Ther 287: 744–751.
5. Benmansour S, Altamirano AV, Jones DJ, Sanchez TA, Gould GG, Pardon MC et al (2004). Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biol Psychiatry 55: 313–316.